Lv1
80 积分 2025-04-14 加入
ctDNA-guided treatment decisions in muscle-invasive bladder cancer
12天前
已完结
Circulating tumour DNA and circulating tumour cells in bladder cancer — from discovery to clinical implementation
12天前
已完结
NSCLC: Five trials to watch
12天前
已完结
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer
3个月前
已完结
Durvalumab after Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer
6个月前
已关闭
Adjuvant immune checkpoint blockade revisited
8个月前
已完结
Neoadjuvant immune checkpoint therapy: Enabling insights into fundamental human immunology and clinical benefit
8个月前
已完结
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
10个月前
已关闭
Nab-paclitaxel plus gemcitabine in patients with locally advanced pancreatic cancer (LAPACT): a multicentre, open-label phase 2 study
10个月前
已完结
Nab-paclitaxel plus gemcitabine versus nab-paclitaxel plus gemcitabine followed by FOLFIRINOX induction chemotherapy in locally advanced pancreatic cancer (NEOLAP-AIO-PAK-0113): a multicentre, randomised, phase 2 trial
10个月前
已完结
皖公网安备34019202002308
